3-Chloro-4,4,5-trimethyl-3,5-diphenyl-4,5-dihydro-3H-pyrazole (3b) and 3-bromo-4,4,5-trimethyl-3,5-diphenyl-4,5-dihydro-3H-pyrazole (3c) were prepared for the thermolysis project. The thermal decompositions of 3b and 3c were monitored using 1H NMR spectroscopy. Plots of ln (% starting material) vs. time (sec) were linear for at least two half lives and the first order rate constants were determined over at least a 30o temperature range. The relative reactivity was found to be 3c > 3b. The activation parameters determined for the thermal decomposition of the pyrazoline at 150oC were found to be: for 3b &#;H‡ = 33 &#;1.0 kcal/mol, &#;S‡ = -2.4 &#; 0.07eu , k150 0 = 7.34 &#; 0.44 x 10 -5 s-1 ; for 3c &#;H‡ = 30&#;0.2 kcal/mol, &#;S‡ = -6.9 &#;0.03 eu, k150o = 42.3&#;0.7 x 10-5 s-1. Thermal decomposition of 3b both neat and in dibromobenzene (DBB) resulted in the formation of an intermediate 2,3-diphenyl-4-methyl-1,3-pentadiene (8) as a major product and minor isomers of 8. These intermediates then thermally decomposed to 1,1,3-trimethyl-2-phenyl-1H-indene (9) via an acid catalyzed process. In order to gain a mechanistic understanding (ionic vs. radical pathways) of the thermal decomposition of 3b, a product study was conducted in protic solvents. In methanol and ethanol, 3b underwent an ionic reaction (SN1-type) with the solvent to produce 3-methoxy/ethoxy-4,4,5-trimethyl-3,5-diphenyl-4,5-dihydro-3H-pyrazole (3/3d) in good yield. The reaction of 3b with refluxing protic solvents led to the development of new method for the synthesis of alkoxy-4,5-dihydro-3H-pyrazoles which is both safe and efficient.

Adverse effects of cyclooxygenase (COX) inhibitors on bone healing have previously been demonstrated in diaphyseal fracture models in animals. In spite of that, they are widely used as postoperative analgesics in orthopaedic surgery. After joint replacement, a bone repair process starts at the interface between bone and cement. If this process is disturbed, the prosthesis may never become rigidly fixed to the bone, leading to migration and with time loosening. This thesis investigates the effects of a selective COX-2 inhibitor (parecoxib or celecoxib) on bone healing in metaphyseal bone in a rat model and on knee prosthesis migration after total knee replacement, as measured with radiostereometric analysis. Blood loss, postoperative recovery, and the 2-year subjective outcome, were also measured. In addition, a hemoglobin dilution method for blood loss estimation, used in this thesis, was evaluated. In the first study, pull-out force of a screw inserted in metaphyseal bone of the tibia in rats was only marginally decreased by parecoxib after 7 days but not after 14 days. In the second and third study, celecoxib treatment resulted in less pain postoperatively in conjunction with total knee replacement (TKR), but no effects were seen on blood loss, range of motion, subjective outcome, or prosthesis migration after 2 years. Comparing the true blood loss of blood donors with the blood loss estimated by the hemoglobin dilution method, this method was found to underestimate the true blood loss. It is therefore not suitable for calculation of the absolute blood loss volume, but may be used for a rough estimate. In summary, celecoxib and presumably other cyclooxygenase inhibitors seems not likely to increase the risk of prosthesis loosening.

Diss. (sammanfattning) Linköping : Linköpings universitet, 2008. / Härtill 4 uppsatser.

Conselho Nacional de Desenvolvimento Científico e Tecnológico / This dissertation first describes the collection of literature data among the years 2005 to 2011 for the subsequent data analysis of 1H NMR chemical shifts and coupling constants and 2JHH 3JHH with emphasis on the synthesis of 3,5-diaryl-4,5-dihydro-1H-pyrazoles. Initially, was analyzed the data from X-ray diffraction of compounds 4,5-dihydro-1H-pyrazoles with a focus on the molecular structure description. Posteriorly, the X-rays data was correlated with the 1H NMR chemical shifts observing the influence of different substituents on the pyrazole ring. The coupling constants 2JHH 3JHH were correlated with bond angles and dihedral angles observed respectively for the molecules of 3,5-diaryl-4,5-dihydro-1H-pyrazoles. / A presente dissertação descreve inicialmente a coleta de dados da literatura entre os anos de 2005 e 2011 para a posterior análise de dados de deslocamento químico de RMN 1H, e constantes de acoplamento 2JHH e 3JHH com ênfase à síntese de 3,5-diaril-4,5-diidro-pirazóis. Primeiramente, foram analisados os dados de difração de raios-X de compostos 4,5-diidro-1H-pirazóis com foco na estrutura molecular descrita. A seguir, correlacionou-se os dados de raios-X com os deslocamentos químicos de RMN 1H observando a influência dos diferentes substituintes sobre o anel pirazolínico. Foram correlacionadas as constantes de acoplamento 2JHH e 3JHH com os ângulos de ligação e ângulos diedros observados, respectivamente, para as moléculas de 3,5-diaril-4,5-diidro-1H-pirazóis.

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior / This work describes firstly an efficient and regioselective method for the synthesis of a new series of 2,2,2-trifluoro-1-[4-methoxy-spiro(2H-chromen-2,1 -cycloalkan)-3-yl]ethanones from the Kabbe adducts (spiro[chroman-2,1 -cycloalkan]-4-ones). Yields of 38 % to 61 % were obtained when trifluoroacetylation reactions of mixtures of enolethers and/or acetals derived from four spiro ketones (Kabbe adducts) were performed at a temperature of 45 oC and employing anhydrous chloroform as the solvent. Subsequently, when the respective trifluoroacetylated Kabbe adducts reacted with phenylhydrazine and methylhydrazine at a 1:1 molar ratio in refluxing ethanol for 24 hours, a new series of seven examples of a novel spiro-condensed heterocyclic system, namely 1(2)-methyl(phenyl)-3-(trifluoromethyl)-1,4(2,4)-dihydro-spiro(chromen[4,3-c]pyrazole-4,n -cycloalkanes) where cycloalkanes are cyclopentane, cyclohexane and cycloheptane (n = 1) and tetrahydro-2H-pyran (n = 2) were isolated at yields of between 35 % and 51 %. NMR and X-ray diffraction techniques demonstrated clearly that reactions from methylhydrazine and phenylhydrazine were regioselective and allowed to isolate separately the 1,3- and 2,3-trifluoromethylated isomers, respectively. Subsequently, two examples of new 3-hydroxy-3-(trifluoromethyl)-3,3a-dihydro-4H-spiro(chromen[4,3-c]isoxazole-4,1 -cycloalkanes), derivated from cyclopentanone and cyclopentanone, were obtained from the reaction of 2,2,2-trifluoro-1-[4-methoxy-spiro(2H-chromen-2,1 -cycloalkan)-3-yl]ethanones with hydroxylamine hydrochloride in yields of 42% and 58%, respectively. Finally, the structures of new spiro heterocycles were determined with the aid and simultaneous application of 1H-, 13C{1H}- and 19F-NMR, X-ray monocrystal diffraction, Mass Spectrometry and DFT calculation techniques and their purity were proved by elemental analysis or High Resolution Mass Spectrometry (HRMS). / O presente trabalho descreve inicialmente um método eficiente e regiosseletivo para a síntese de uma nova série de 2,2,2-triflúor-1-[4-metóxi-espiro(2H-cromen-2,1 -cicloalcan)-3-il]etanonas a partir de adutos de Kabbe (espiro[croman-2,1 -cicloalcan]-4-onas). Rendimentos de 38% a 61% foram obtidos quando reações de trifluoracetilação de misturas de enoléteres e/ou acetais derivados de quatro espiro cetonas (adutos de Kabbe) foram realizadas a 45 ºC usando clorofórmio anidro como solvente. Subsequentemente, quando os respectivos adutos de Kabbe trifluoracetilados foram reagidos com fenilhidrazina ou metilhidrazina, em relação molar de 1:1, sob refluxo de etanol por 24 horas, uma série de sete exemplares de um novo sistema heterocíclico espiro-condensado, denominado 1(2)-metil(fenil)-3-(trifluormetil)-1,4(2,4)-diidro-espiro(chromen[4,3-c]pirazol-4,n -cicloalcanos) onde os cicloalcanos são ciclopentano, ciclohexano e cicloheptano (n = 1) e tetraidro-2H-pirano (n = 2), foi isolada em rendimentos entre 35 % e 51 %. Técnicas de RMN e de difração de raios-X demonstraram claramente que as reações a partir da metilhidrazina e da fenilhidrazina foram regiosseletivas e permitiram isolar separadamente os isômeros trifluormetilados 1,3 e 2,3, respectivamente. Em sequência, dois exemplares de novas 3-hidróxi-3-(trifluormetil)-3,3a-diidro-4H-espiro(cromen[4,3-c]isoxazol-4,1 -cicloalcanos), derivados da ciclopentanona e ciclohexanona, foram obtidos a partir da reação de 2,2,2-triflúor-1-[4-metóxi-espiro(2H-cromen-2,1 -cicloalcan)-3-il]etanonas com cloridrato de hidroxilamina em rendimentos de 42% e 58%, respectivamente. Finalmente, as estruturas dos novos espiro heterociclos foram determinadas com o auxílio e aplicação simultânea de experimentos de RMN de 1H, 13C{1H}, 19F, difração de raios-X em monocristais, Espectrometria de Massas e cálculos DFT e, a sua pureza comprovada por Análise Elementar ou por Espectrometria de Massas de Alta Resolução (HRMS).

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior / The synthesis of two series of N-substituted pyrazoles from the cyclocondensation reaction of β-enaminones ([R1C(O)C(R2)=CHN(Me2)], where R1 = Me, C6H5, 3-MeOC6H4, 4-Me-C6H4, 4-MeO-C6H4, 4-F-C6H4, 4-Cl-C6H4, 4-Br-C6H4, 4-O2N-C6H4, fur-2-il, thien-2-il; R2 = H, 2-MeO-C6H4) and 2-hydroxyethylhydrazine or 1-pentafluorophenylhydrazine was demonstrated. The reactions were performed in five ionic liquids ([BMIM][BF4], [BMIM][Br], [BMIM][OH], [HMIM][HSO4] e [BPy][BF4]) with different physical and chemical properties to establish the best reaction conditions. In addition, a Brönsted (HCl) and a Lewis catalyst (BF3●OEt2) and two molecular solvents (ethanol and water) were evaluated. The best ionic liquid found for all reactions was [BMIM][BF4]; molecular solvent ethanol for reaction with 2- hydroxyethylhydrazine; and water for reaction with 1-pentafluorophenylhydrazine. On the other hand, in the case of the reaction with 2-hydroxyethylhydrazine, BF3●OEt2 was found to be the best catalyst, while with 1- pentafluorophenylhydrazine, HCl, was found to be the best one, when comparing both reactions in [BMIM][BF4]. In general, the results showed it is advantage in yields and reaction time the use of ionic liquids in relation to molecular solvents. This work also shows the synthesis and characterization of a series of ionic liquids containing a pharmacological cation and/or anion. The new ionic liquids were synthesized from the metathesis reaction between the lidochaine, benzalkonium or didecyldimethylamonium salts, to furnish the cation part; and sodium diclofenac, sodium flurbiprofenate, sodium flufenamicate, sodium salicylate, sodium saccharinate and potassium acesulfamate, to furnish the anion part. The new ionic liquids were obtained in moderate to good yields (56-89%) and were identified and characterized through the NMR, DSC and TGA data. / Este trabalho descreve a síntese de duas séries de pirazóis N-substituídos, a partir da reação de ciclocondensação entre β-enaminonas ([R1C(O)C(R2)=CHN(Me2)], onde R1 = Me, C6H5, 3-MeO-C6H4, 4-Me-C6H4, 4-MeO-C6H4, 4-F-C6H4, 4-Cl-C6H4, 4- Br-C6H4, 4-O2N-C6H4, fur-2-il, tien-2-il; R2 = H, 2-MeO-C6H4) e 2-hidroxietilidrazina ou 1-pentafluorfenilidrazina. As reações foram realizadas em diferentes líquidos iônicos ([BMIM][BF4], [BMIM][Br], [BMIM][OH], [HMIM][HSO4] e [BPy][BF4]) com propriedades físicas e químicas diferentes a fim de estabelecer as melhores condições para a obtenção dos 1-hidroxietilpirazóis e dos 1-pentafluorfenilpirazóis. Além disso, também foram avaliados diferentes catalisadores (HCl e BF3●OEt2) e dois solventes moleculares (etanol e água). Em ambos os casos, o líquido iônico [BMIM][BF4] apresentou os melhores resultados. No entanto, quanto ao catalisador avaliado, foi verificado um comportamento distinto. A reação entre hidroxietilidrazina e enaminonas [BMIM][BF4] foi melhor quando BF3●OEt2 foi utilizado como catalisador, enquanto que para a reação da pentafluorfenilidrazina, HCl se mostrou mais adequado. Além disso, o melhor solvente molecular encontrado para a reação com a 2-hidroxietilidrazina foi o etanol enquanto que no caso da 1- pentafluorfenilidrazina, a água apresentou resultados superiores em termos de tempo reacional e rendimento. Através dos resultados obtidos foi possível observar que a utilização de líquidos iônicos apresenta vantagens em relação a utilização de solventes moleculares. Nesta tese, também foram sintetizadas series de líquidos iônicos contendo componentes farmacologicamente ativos, tanto no cátion quanto no ânion do referido composto. Os novos líquidos iônicos duais foram sintetizados através de uma reação de metátese entre sais de lidocaína, benzalcônio ou didecildimetilamônio, os quais forneceram a parte catiônica, com diferentes sais como, diclofenaco de sódio, flurbiprofenato de sódio, flufenamicato de sódio, salicilato de sódio, sacarinato de sódio e acesulfamato de potássio. Esses compostos foram obtidos em rendimentos moderados a bons (56-89%), e foram identificados e caraterizados através de dados de RMN, DSC e TGA.

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior / Oxidative stress is involved in several neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis. Oxidative stress seems to be involved in the pathology of dementia/amnesia. It has been suggested that oxidative stress impairs the muscarinic cholinergic system triggering Alzheimer's disease. The muscarinic antagonist scopolamine has been used to induce amnesia in animals. This experimental model has been used in screening anti-amnesic drugs that could be useful for the treatment of dementia. The aim of this study was to evaluate the possible in vitro antioxidant effect of a series of pyrazoline derivatives newly synthesized: (1) 5-hydroxy-3-methyl-5-trifluoromethyl-4,5-dihydro-1H-carbaldehyde-pyrazole, (2) 5-hydroxy-3-methyl-5- trifluoromethyl-4,5-dihydro-1H-1-acetyl-pyrazole, (3) 5-hydroxy-3-methyl-5-trifluoromethyl-4,5-dihydro-1H-carboxyamide-pyrazole, (4) 5-hydroxy-3-methyl-5-trifluoromethyl-4,5-dihydro-1H-1-benzoyl-pyrazole, (5) 5-hydroxy-3-methyl-5-trifluoromethyl-4,5-dihydro-1H-1-(2- hydroxybenzoyl)-pyrazole and (6) 5-hydroxy-3-methyl-5-trifluoromethyl-4,5-dihydro-1H-1-(4-methoxybenzoyl)-pyrazole. Besides, considering the possible involvement of oxidative stress in dementia, the compound that was the most effective in vitro was assessed concerning to its ability to prevent the memory deficit and oxidative stress in a scopolamine-induced amnesia model. Compound (5) had the highest antioxidant capacity in vitro, since it reduced lipid peroxidation (TBARS) basal and stimulated by the pro-oxidants iron, hydrogen peroxide and sodium nitroprusside, having significant effects from 15 μM onwards (p<0.05). Compound (5) also protected against hydrogen peroxide-induced glutathione oxidation, with a significant effect at the concentration of 150 μM (p<0.05). This compound also had the highest total antioxidant activity, demonstrated by its ability to remove the radical 1,1-dyphenyl-2-pycrylhydrazyl (DPPH). Compounds (1) and (4) also reduced lipid peroxidation basal and stimulated by iron and sodium nitroprusside, having significant effects from 15 μM onwards (p<0.05). Compound (2) had the highest ability to reduce iron (p<0.05). Scopolamine administration 30 min before training session resulted in shorter latency to step-down during the test session of the inhibitory avoidance task (p<0.05). Pretreatment with pyrazole compound (5) had no effect per se on the step-down latency. However, pretreatment with compound (5) (100 μmol/kg) 30 min before scopolamine did prevent the amnesic effect of scopolamine (p<0.05). No significant effect of scopolamine or pyrazole treatment was observed on any of the oxidative stress markers evaluated (thiobarbituric acid reactive substances, non-protein sulfhydrylic groups content and activity of enzymes superoxide dismutase and catalase) suggesting that the protective effect of compound (5) was not related to a possible antioxidant activity. Results revealed that pyrazole compound (5) has in vitro antioxidant activity as well as neuroprotective activity in a model of amnesia. These findings suggest that compound (5) could be a promising drug for the treatment of Alzheimer´s disease. However, further studies are needed to elucidate the mechanisms involved in the antiamnesic effect of this compound, as well as its effect on other dementia models. / O estresse oxidativo está envolvido em diversas doenças neurodegenerativas importantes, tais como a doença de Alzheimer, a doença de Parkinson e a esclerose lateral amiotrófica. O estresse oxidativo parece estar envolvido na patologia da demência/amnésia, tendo sido sugerido que as alterações cerebrais decorrentes deste causam danos ao sistema colinérgico muscarínico e que desta forma desencadeiam a doença de Alzheimer. A escopolamina, um antagonista muscarínico, tem sido usado para induzir amnésia em animais, em um modelo experimental para a triagem de drogas que poderiam ser úteis no tratamento da demência. O principal objetivo deste estudo foi avaliar o possível efeito antioxidante in vitro de uma série de derivados pirazolínicos recém sintetizados: (1) 5-hidroxi-3-metil-5-trifluorometil-4,5-diidro-1H-carbaldeido-pirazol, (2) 5-hidroxi-3-metil-5- trifluorometil-4,5-diidro-1H-1-acetil-pirazol, (3) 5-hidroxi-3-metil-5-trifluorometil-4,5-diidro-1Hcarboxiamida- pirazol, (4) 5-hidroxi-3-metil-5-trifluorometil-4,5-diidro-1H-1-benzoil-pirazol, (5) 5-hidroxi-3-metil-5-trifluorometil-4,5-diidro-1H-1-(2-hidroxibenzoil)-pirazol e (6) 5-hidroxi-3-metil-5-trifluorometil-4,5-diidro-1H-1-(4-methoxibenzoil)-pirazol. Além disso, considerando o possível envolvimento do estresse oxidativo na demência, foi avaliada a capacidade do composto mais efetivo in vitro, em prevenir o déficit de memória e o estresse oxidativo em um modelo de amnésia induzida por escopolamina. O derivado pirazolínico (5) apresentou maior capacidade antioxidante in vitro, pois foi o mais efetivo para reduzir a lipoperoxidação (TBARS) basal e induzida pelos pró-oxidantes ferro, peróxido de hidrogênio e nitroprussiato de sódio, tendo efeitos significativos a partir de 15 μM (p<0,05). O composto (5) também protegeu a glutationa da oxidação induzida por peróxido de hidrogênio, tendo efeito significativo na concentração de 150 μM (p<0,05). Este composto também foi o que teve maior atividade antioxidante total, demonstrada pela sua capacidade de remover o radical 1,1-difenil-2-picrilhidrazil (DPPH). Os compostos (1) e (4) também reduziram a lipoperoxidação basal e induzida por ferro e nitroprussiato de sódio, tendo efeitos significativos a partir de 15 μM (p<0,05). O composto (2) apresentou a maior capacidade de redução de ferro (p<0,05). A administração de escopolamina 30 min antes do treino provocou amnésia, medida como a redução na latência para descer da plataforma no teste de esquiva inibitória (p<0.05). O pré-tratamento com o composto (5) 30 min antes da escopolamina não apresentou efeito per se na latência, mas preveniu o efeito amnésico da escopolamina, na dose de 100 μmol/kg (p<0.05). Não foi observado efeito significativo da escopolamina ou do composto (5) em qualquer dos marcadores de estresse oxidativo avaliados (substâncias reativas ao ácido tiobarbitúrico, grupos tiólicos não protéicos e atividade das enzimas superóxido dismutase e catalase), sugerindo que o efeito protetor do composto (5) não está relacionado à sua atividade antioxidante. Os resultados obtidos demonstram que o composto (5) apresenta atividade antioxidante in vitro e neuroprotetora em um modelo de amnésia, sugerindo que este composto pode ser promissor para o tratamento da doença de Alzheimer. No entanto, outros estudos são necessários para elucidar os mecanismos envolvidos na ação anti-amnésica deste composto, bem como o seu efeito em outros modelos de demência.

Title: Phosphinoferrocene amides and hydrazides Author: Hana Solařová Department: Department of Inorganic Chemistry Supervisor: doc. RNDr. Petr Štěpnička, Ph.D. Abstract: While studying functionalized phosphinoferrocene ligands, we recently turned to phosphinoferrocene carboxamides. These donors already proved to be versatile ligands for coordination chemistry and catalysis. This led us to synthesize and study the archetypal representative, 1'-(diphenylphosphino)-1-carbamoylferrocene (5), and the corresponding hydrazide 6. PPh2 COOH Fe Hdpf PPh2 CONH2 Fe 5 PPh2 CONHNH2 Fe 6 This work describes the preparation of primary amide 5 and hydrazide 6 from 1'- (diphenylphosphino)-1-ferrocenecarboxylic acid (Hdpf) via the corresponding acylbenzo- triazole derivative. The hydrazide was alternatively obtained from Hdpf methylester and hydrazine hydrate. Both newly synthesized compounds were characterized by spectroscopic methods (NMR, IR, and MS) and elemental analysis, and their crystal structures were determined by single-crystal X-ray crystallography. The amide was further utilized in the preparation of several palladium complexes, which were characterized in a similar manner including X-ray crystallography. One palladium complex was obtained also from the hydrazide. However, the hydrazide was used mainly as a...

Les imidazo[1,2-b]pyrazoles tout comme les imidazo[1,2-a]imidazoles sont des entités présentant diverses applications intéressantes notamment dans le domaine pharmacologique. Cependant, malgré ce potentiel, ces structures hétérobicycliques ont été, jusqu’à ce jour, relativement peu étudiées tant au niveau de leur préparation que de leur fonctionnalisation. De ce fait, ces travaux de thèse ont pour objet la mise au point de nouvelles voies d’accès à ces systèmes bicycliques et ce, au départ de substrats facilement accessibles. Des stratégies de fonctionnalisation de ces charpentes moléculaires ont ensuite été développées dans le but de concevoir des librairies diversifiées de ce type de composés, librairies destinées à être évaluées biologiquement. Les premiers résultats d’évaluation sur des lignées cancéreuses de dérivés imidazo[1,2-b]pyrazoliques sont également présentés. / Imidazo[1,2-b]pyrazoles and imidazo[1,2-a]imidazoles are entities with some interesting applications in pharmacology. However, despite this potential, few methods of preparation and direct functionalisation of the heterocyclic moiety have been described. In this context, the overall goal of our research is to develop new routes to these bicyclic systems from readily available starting materials. Strategies of functionalisation of the heterocyclic moiety were then explored in order to design diversified libraries for the evaluation of potential biological activities. Herein, the results of the tests of imidazo[1,2-b]pyrazole series against various cancer lines are reported.

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior / The regioespecific synthesis of a series of 14 N-acylated enaminones (52-88%) from the acylation reaction of secondary β-enamino ketones [RC(O)CH=CHNR1R2; R = Ph, 4- FC6H4, 4-NO2C6H4, thien-2-yl, CCl3, CF3; R1 = H; R2 = Bn, Ph, 4-NO2C6H4] with trifluoroacetic anhydride or ethyl oxalyl chloride in pyridine is reported. On the other hand, when tertiary enaminone precursors [R = Ph, 4-MeC6H4, 4-MeOC6H4, 4-BrC6H4, 4-ClC6H4, 4-FC6H4, 4-O2NC6H4, thien-2-yl, benzofur-2-yl, CCl3, CF3; R1,R2 = Me] were used, the acylation reaction led to a series of 17 C-acylated enaminones (75-95%). A series of 4-substituted-1H-pyrazole-5-carboxylates (73-94%) were obtained regiospecifically from the cyclocondensation reaction of non symmetrical enaminodiketones [RC(O)C(=CHNMe2)C(O)CO2Et; R = Ph, 4-MeOC6H4, 4-ClC6H4, 4-FC6H4, 4-O2NC6H4, thien-2-yl, benzofur-2-yl, CCl3, CF3] with tert-butylhydrazine or carboxymethylhydrazine. The reaction of these pyrazole-5-carboxylates (R = 4-MeOC6H4, 4-FC6H4, benzofur-2-yl, CF3) with hydrazine lead to synthesis of 4- substituted-pyrazolo[3,4-d]pyridazinones (74-96%). In addition, the reaction of enaminodiketones (R = Ph, 4-MeC6H4, 4-MeOC6H4, 4-BrC6H4, 4-ClC6H4, 4-FC6H4, 4- O2NC6H4, thien-2-yl, benzofur-2-yl) with 3-amino-5-methylpyrazole was performed, where a series of pyrazolo[1,5-a]pyrimidine-7-carboxylates were obtained regiospecifically (53-79%). / A síntese de uma série de 14 enaminonas N-aciladas regioespecificamente (52-88%) foi realizada a partir da reação de acilação de enaminonas secundárias [RC(O)CH=CHNR1R2; R = Ph, 4-FC6H4, 4-NO2C6H4, tien-2-il, CCl3, CF3; R1 = H; R2 = Bn, Ph, 4-NO2C6H4] com anidrido trifluoracético e com cloreto de etil oxalila em piridina. Quando foram utilizados como precursores enaminonas terciárias [R = Ph, 4-MeC6H4, 4-MeOC6H4, 4-BrC6H4, 4-ClC6H4, 4-FC6H4, 4-O2NC6H4, tien-2-il, benzofur-2-il, CCl3, CF3; R1,R2 = Me] a reação de acilação levou à obtenção regioespecífica de 17 enaminonas C-aciladas (75-95%). Uma série de 5-carboxietil-1H-pirazol 4-substituídos foi obtida regioespecificamente (73-94%) a partir da ciclocondensação das enaminodicetonas não simétricas [RC(O)C(=CHNMe2)C(O)CO2Et; R = Ph, 4-MeOC6H4, 4-ClC6H4, 4-FC6H4, 4-O2NC6H4, tien-2-il, benzofur-2-il, CCl3, CF3] com tert-butilidrazina ou carboximetilidrazina. A reação destes pirazóis (R = 4-MeOC6H4, 4-FC6H4, benzofur-2-il, CF3) com hidrazina monoidrato levou à síntese de pirazolo[3,4-d]piridazinona 4- substituídas (74-96%). Também foi realizada a reação de ciclocondensação de enaminodicetonas (R = Ph, 4-MeC6H4, 4-MeOC6H4, 4-BrC6H4, 4-ClC6H4, 4-FC6H4, 4-O2NC6H4, tien-2-il, benzofur-2-il) com 3-amino-5-metilpirazol onde as 7-carboxietilpirazolo[1,5-a]pirimidinas 6-substituídas foram obtidas regioespecificamente (53-79%).